An information platform for unlisted & pre-IPO sharesNot a SEBI-recognised stock exchange or trading platformAll prices are indicative
UnlistedZone
HomeKnowledgePharmEasy's sales cross INR 6000cr. Mark in FY23
Knowledge03 Feb 2024

PharmEasy's sales cross INR 6000cr. Mark in FY23

Disclaimer: This article is for informational purposes only and is not investment advice, nor an offer to buy or sell any security. Unlisted share prices are indicative. Please do your own research or consult a SEBI-registered advisor before investing.
Share this